STRUCTURAL REQUIREMENTS FOR HG(II) ANTIDOTES

[1] AASETH J, 1976, ACTA PHARMACOL TOX, V39, P289

[2] PROTECTION BY D-PENICILLAMINE AGAINST THE LETHAL EFFECTS OF MERCURIC CHLORIDE [J]. SCIENCE, 1958, 128 (3315) : 93 - 93

[3] APOSHIAN HV, 1959, J PHARMACOL EXP THER, V126, P131

[4] PENICILLAMINE AND ANALOGOUS CHELATING AGENTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) : 481 - &

[5] AYLETT BJ, 1973, COMPREHENSIVE INORGA, V3, P310

[6] BELONOZHKO G, 1957, VRACH DELO

[7] BELONOZHKO G A, 1958, Farmakol Toksikol, V21, P69

[8] BERLIN M, 1964, ACTA PHARM, V22, P1

[9] Beurskens P. T., 1971, J MOL CRYST STRUCT, V1, P93

[10] BRINKHOF.HC, 1970, RECL TRAV CHIM PAY-B, V89, P11

[1] AASETH J, 1976, ACTA PHARMACOL TOX, V39, P289

[2] PROTECTION BY D-PENICILLAMINE AGAINST THE LETHAL EFFECTS OF MERCURIC CHLORIDE [J]. SCIENCE, 1958, 128 (3315) : 93 - 93

[3] APOSHIAN HV, 1959, J PHARMACOL EXP THER, V126, P131

[4] PENICILLAMINE AND ANALOGOUS CHELATING AGENTS [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) : 481 - &

[5] AYLETT BJ, 1973, COMPREHENSIVE INORGA, V3, P310

[6] BELONOZHKO G, 1957, VRACH DELO

[7] BELONOZHKO G A, 1958, Farmakol Toksikol, V21, P69

[8] BERLIN M, 1964, ACTA PHARM, V22, P1

[9] Beurskens P. T., 1971, J MOL CRYST STRUCT, V1, P93

[10] BRINKHOF.HC, 1970, RECL TRAV CHIM PAY-B, V89, P11